6533b855fe1ef96bd12b00ab
RESEARCH PRODUCT
The tumour microenvironment as an integrated framework to understand cancer biology
Luis De La Cruz-merinoRosa NogueraEsther Gamero-sandemetrioFederico LucantoniTomás ÁLvaroRebeca Burgos-panaderosubject
0301 basic medicineCancer ResearchStromal cellBiophysicsDiseaseBiologyExtracellular matrix03 medical and health sciences0302 clinical medicineGermline mutationImmune systemNeoplasmsTumor MicroenvironmentmedicineStromal classificationAnimalsHumansCompartment (development)CancerExtracellular matrixmedicine.diseaseBioelectricExtracellular MatrixMetabolism030104 developmental biologyOncologyCancer treatment030220 oncology & carcinogenesisCancer cellStromal CellsNeurosciencedescription
Cancer cells all share the feature of being immersed in a complex environment with altered cell-cell/cell-extracellular element communication, physicochemical information, and tissue functions. The so-called tumour microenvironment (TME) is becoming recognised as a key factor in the genesis, progression and treatment of cancer lesions. Beyond genetic mutations, the existence of a malignant microenvironment forms the basis for a new perspective in cancer biology where connections at the system level are fundamental. From this standpoint, different aspects of tumour lesions such as morphology, aggressiveness, prognosis and treatment response can be considered under an integrated vision, giving rise to a new field of study and clinical management. Nowadays, somatic mutation theory is complemented with study of TME components such as the extracellular matrix, immune compartment, stromal cells, metabolism and biophysical forces. In this review we examine recent studies in this area and complement them with our own research data to propose a classification of stromal changes. Exploring these avenues and gaining insight into malignant phenotype remodelling, could reveal better ways to characterize this disease and its potential treatment.
year | journal | country | edition | language |
---|---|---|---|---|
2019-07-17 | Cancer Letters |